A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar
Doua AlSaad,1 Samah ElSalem,1 Palli Valapila Abdulrouf,1 Binny Thomas,1,2 Tayseer Alsaad,3 Afif Ahmed,1 Moza AlHail4 1Department of Pharmacy, Women’s Hospital, Hamad Medical Corporation, Doha, Qatar; 2Department of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK; 3Depar...
Main Authors: | AlSaad D, ElSalem S, Abdulrouf PV, Thomas B, Alsaad T, Ahmad A, AlHail M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-02-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/a-retrospective-drug-use-evaluation-of-cabergoline-for-lactation-inhib-peer-reviewed-article-TCRM |
Similar Items
-
Is Cabergoline Safe and Effective for Postpartum Lactation Inhibition? A Systematic Review
by: Yang Y, et al.
Published: (2020-03-01) -
CABERGOLINE IN PRACTICAL MAMMOLOGY
by: I. V. Vysotskaya, et al.
Published: (2016-12-01) -
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
by: Rosa Pirchio, et al.
Published: (2021-11-01) -
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
by: Shruti Khare, et al.
Published: (2017-01-01) -
No link to cardiac valvulopathy was seen in cabergoline treated patients
by: K Dharshini, et al.
Published: (2012-10-01)